lenalidomide,rituximab,acalabrutinib
astrazeneca
['mantle,(-dismantle)', 'lenalidomide', 'obinu', 'beyond,trial', 'ritux', 'acalabrutinib', ' lena', '2018', 'lymphoma', 'lymsm', 'imab ']
congress | #ash22 jia ruan md, of , presents data from a phase ii trial of acalabrutinib-lenalidomide-rituximab in patients with treatment-na ve #mcl. the combination was well tolerated, highly effective, and produced high rates of mrd-negativity.
#lymsm 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm